The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Key company metrics

  • Trailing P/E--
  • P/E 1 year forward4.88×
  • Forward PEG0.57×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS--
 Delayed by at least 15 minutes.
S&P TSX1.19%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Total other revenue--------
Total revenue2,1092,4032,4802,420
Gross profit1,5131,7371,8221,762
Total cost of revenue596665658658
Total operating expense1,9622,2523,3432,340
Selling / general / administrative661665661672
Research & development9693101124
Depreciation / amortization635284807888
Interest expense (income), net operating--------
Unusual expense (income)-274531,11544
Other operating expenses, total1931-45
Operating income147150-86381
Interest income (expense), net non-operating-474-467-470-473
Gain (loss) on sale of assets--------
Income before tax-295-360-1,332-377
Income after tax629-512-1,219-304
Income tax, total-924152-113-73
Net income628-515-1,218-302
Total adjustments to net income--------
Net income before extra. items628-515-1,218-302
Minority interest-1-312
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items628-515-1,218-302
Inc. avail. to common incl. extra. items628-515-1,218-302
Diluted net income627-515-1,218-302
Dilution adjustment-1----0
Diluted weighted average shares351350350345
Diluted EPS excluding extraordinary itemsvalue per share1.79-1.47-3.49-0.88
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.74-0.65-1.38-0.78